Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 8/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 1.00 |
| ▸ | HPGD | P15428 | 7/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 1.00 |
| ▸ | AKR1B1 | P15121 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 0.70 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.70 |
| ▸ | CASP1 | P29466 | 5/20 | 0.62 |
| ▸ | CASP7 | P55210 | 5/20 | 0.62 |
| ▸ | GAA | P10253 | 4/20 | 0.62 |
| ▸ | GLA | P06280 | 3/20 | 0.62 |
| ▸ | CA9 | Q16790 | 3/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | CA12 | O43570 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4-Methylesculetin SCHEMBL29361762 | 1.00 | MCL1 (1.00) | MCL1ALDH1A1KDM4EHPGDHSD17B10 | |
| 4-Methylesculetin SCHEMBL6839210 | 0.98 | MCL1 (0.96) | MCL1ALDH1A1KDM4EHPGDHSD17B10 | |
| 4-Methylesculetin SCHEMBL27453331 | 0.98 | ALDH1A1 (0.96) | MCL1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL24865598 | 0.90 | ALDH1A1 (0.82) | MCL1ALDH1A1KDM4EHPGDHSD17B10 | |
| 4-Methylesculetin SCHEMBL6262439 | 0.88 | MCL1 (0.78) | MCL1ALDH1A1KDM4EHPGDHSD17B10 | |
| 4-Methylesculetin SCHEMBL7798943 | 0.86 | KDM4E (0.73) | MCL1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL6904172 | 0.85 | ALDH1A1 (0.74) | MCL1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL22031603 | 0.85 | ALDH1A1 (0.74) | MCL1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL580501 | 0.85 | ALDH1A1 (0.74) | MCL1ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL31357189 | 0.85 | MCL1 (1.00) | MCL1ALDH1A1KDM4EHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 561 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119241823-B | High-molecular efficient nucleating agent and preparation method and application thereof | TSINGHUA UNIVERSITY (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122070479-A | Ultrasonic indicating device and method for monitoring ultrasonic treatment | JP实验室股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | APEEL TECH INC (US) | 2026-04-09 | — | — | US | claimed |
| US-20250354152-A1 | PHARMACEUTICAL COMPOUND FOR PREVENTION OR TREATMENT OF LIVER FIBROSIS | MEDIZINISCHE HOCHSCULE HANNOVER (DE) | 2025-11-20 | — | — | US | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| CN-119606945-B | Application of 4-methyl esculetin as potential active ingredient of XIASANGJU in preparation of medicine for preventing and treating diabetes | 广州白云山星群(药业)股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| WO-2025090061-A1 | ULTRASONIC INDICATOR DEVICE AND METHOD FOR MONITORING ULTRASONICATION | JP LABORATORIES, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| EP-4536826-A1 | PHARMACEUTICAL COMPOUND FOR PREVENTION OR TREATMENT OF LIVER FIBROSIS | Medizinische Hochschule Hannover (DE) | 2025-04-16 | — | — | EP | claimed |
| WO-2025075611-A1 | ULTRASONIC INDICATOR BASED ON EMULSION FORMATION | JP LABORATORIES, INC. (US) | 2025-04-10 | — | — | WO | claimed |
| CN-119606945-A | Application of 4-methyl esculetin as potential active ingredient of XIASANGJU in preparation of medicine for preventing and treating diabetes | 广州白云山星群(药业)股份有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-1159131-A | Electroluminescent devices | BAYER AG (DE) | 1997-09-10 | — | — | CN | claimed |
| US-5663029-A | DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| US-5455268-A | Treating arthropathy | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1995-10-03 | — | — | US | claimed |
| EP-0290442-A4 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS. | CHEMEX PHARMACEUTICALS INC (US) | 1990-07-03 | — | — | EP | claimed |
| EP-0290442-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-11-17 | — | — | EP | claimed |
| WO-1988003805-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-06-02 | — | — | WO | claimed |
| US-4711836-A | Development of positive-working photoresist compositions | OLIN HUNT SPECIALTY PRODUCTS, INC. (US) | 1987-12-08 | — | — | US | claimed |
| EP-0031202-B1 | NEW POLYESTER COMPOSITIONS; SHAPED ARTICLES OBTAINED FROM THEM AND PROCESSES FOR PREPARING THEM | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-10-03 | — | — | EP | claimed |
| US-4347350-A | Polyester compositions containing residues of dihydroxyalkoxy coumarins | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1982-08-31 | — | — | US | claimed |
| EP-0031202-A2 | New polyester compositions; shaped articles obtained from them and processes for preparing them | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1981-07-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096569-A1 | EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES | CYP51A1, ERG28, NISCH | MCL1 2738/4885ALDH1A1 1286/4885KDM4E 1123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.